WebNVAX Novavax Inc. Analyst Estimates & Rating – WSJ NVAX (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 04/06/23 $8.46 USD 0.87 11.46% PRE MARKET … Web2 dagen geleden · Why NVAX Stock Can Soar Almost 12 Times. According to Statista, global revenue from the coronavirus vaccine is expected to reach $26 billion next year. Let’s say that Novavax gets 15% of that revenue. That equates to $3.9 billion. Meanwhile, revenue from flu vaccines came in at $4.28 billion in 2024.
Novavax Outlook: Why NVAX Stock Could 12X in the Next 12 …
Web28 jul. 2024 · Here are the three things that will make it or break it for the clinical stage biotech. Image source: Getty Images. 1. A regulatory update. Earlier this year, investors … Web12 apr. 2024 · Novavax, Inc. has a 12-month low of $5.61 and a 12-month high of $76.77. The firm has a market capitalization of $778.98 million, a P/E ratio of -1.08 and a beta of 1.73. The stock's fifty day simple moving average is $8.11 and its 200-day simple moving average is $13.33. Novavax ( NASDAQ:NVAX - Get Rating) last posted its quarterly … havilah ravula
Novavax Inc. (NASDAQ: NVAX) Surged 5.31%, So What Now?
Web5 aug. 2024 · Novavax reported a net loss of $352 million, or $4.75 per share, for the second quarter of 2024, compared to a net loss of $18 million, or $0.30 per share, for … Web10 feb. 2024 · Syndax Pharmaceuticals has delivered an earnings surprise of 95.39%, on average. In the last reported quarter, SNDX reported an earnings surprise of … Web3 mei 2024 · VRTX is scheduled to report earnings on May 5, after the closing bell.In the past 30 days, estimates for Vertex Pharmaceuticals’ 2024 earnings per share have increased from $14.52 to $14.56.... havilah seguros